• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留肾单位手术与根治性肾输尿管切除术治疗高危中下段输尿管尿路上皮癌的疗效比较:一项回顾性分析

Comparative efficacy of kidney-sparing surgery versus radical nephroureterectomy for high-risk middle-lower ureteral urothelial carcinoma: a retrospective analysis.

作者信息

Wang Cheng, Shang PanFeng, Zhang Biao, Kang ZiMing, Ou ShuZhen, Xu WanRong, Li HengPing, Wan JiangHou

机构信息

Department of Urology, Lanzhou University Second Hospital, Chengguan District, Lanzhou, 730030, Gansu, China.

Lanzhou University, Lanzhou, Gansu, China.

出版信息

Int Urol Nephrol. 2025 Jun 22. doi: 10.1007/s11255-025-04618-8.

DOI:10.1007/s11255-025-04618-8
PMID:40545490
Abstract

BACKGROUND

Upper tract urothelial carcinoma (UTUC) is a rare and aggressive malignancy. The standard treatment, radical nephroureterectomy (RNU), may lead to renal function deterioration in high-risk patients. Kidney-sparing surgery (KSS) offers an alternative, but its efficacy in high-risk UTUC, especially for high-risk middle-lower ureteral urothelial carcinoma (UUC), is not well-established.

METHODS

We conducted a retrospective analysis of 181 patients with high-risk middle-lower UUC treated between 2013 and 2023 at three hospitals in China. Patients were categorized into RNU (n = 155) and KSS (n = 26) groups. Propensity score matching (PSM) was used to balance baseline characteristics between groups. Perioperative outcomes and long-term survival were compared.

RESULTS

After PSM, the KSS group showed significantly reduced surgery duration and blood loss compared to the RNU group. No significant differences were observed in transfusion rate, perioperative complications, resection margins, and hospitalization duration. In terms of prognosis, no significant differences were found in overall survival (OS), cancer-specific survival (CSS), intravesical recurrence-free survival (IVRFS), and metastasis-free survival (MFS) between the two groups post-PSM. Multivariate analysis identified T-stage as an independent risk factor for CSS.

CONCLUSION

KSS may be a feasible alternative to RNU in selected high-risk middle-lower UUC patients, with comparable long-term survival.

摘要

背景

上尿路尿路上皮癌(UTUC)是一种罕见且侵袭性强的恶性肿瘤。标准治疗方法根治性肾输尿管切除术(RNU)可能会导致高危患者的肾功能恶化。保留肾手术(KSS)提供了一种替代方案,但其在高危UTUC中的疗效,尤其是对于高危中下段输尿管尿路上皮癌(UUC),尚不明确。

方法

我们对2013年至2023年在中国三家医院接受治疗的181例高危中下段UUC患者进行了回顾性分析。患者分为RNU组(n = 155)和KSS组(n = 26)。采用倾向评分匹配(PSM)来平衡两组之间的基线特征。比较围手术期结果和长期生存率。

结果

PSM后,KSS组与RNU组相比,手术时间和失血量显著减少。在输血率、围手术期并发症、切缘和住院时间方面未观察到显著差异。在预后方面,PSM后两组之间的总生存期(OS)、癌症特异性生存期(CSS)、膀胱内无复发生存期(IVRFS)和无转移生存期(MFS)均未发现显著差异。多变量分析确定T分期是CSS的独立危险因素。

结论

对于选定的高危中下段UUC患者,KSS可能是RNU的一种可行替代方案,长期生存率相当。

相似文献

1
Comparative efficacy of kidney-sparing surgery versus radical nephroureterectomy for high-risk middle-lower ureteral urothelial carcinoma: a retrospective analysis.保留肾单位手术与根治性肾输尿管切除术治疗高危中下段输尿管尿路上皮癌的疗效比较:一项回顾性分析
Int Urol Nephrol. 2025 Jun 22. doi: 10.1007/s11255-025-04618-8.
2
Kidney-Sparing Surgery Has Equivalent Oncological Outcomes to Radical Nephroureterectomy for Ureteral Urothelial Carcinoma.保肾手术与根治性肾输尿管切除术治疗输尿管尿路上皮癌的肿瘤学结局相当。
J Endourol. 2024 Sep;38(9):921-928. doi: 10.1089/end.2024.0061. Epub 2024 Jun 11.
3
Comparison of the oncological and functional outcomes among patients with high-risk upper tract urothelial cancer undergoing segmental ureterectomy based on tumour location.根据肿瘤位置接受节段性输尿管切除术的高危上尿路尿路上皮癌患者的肿瘤学和功能结局比较。
BJUI Compass. 2025 Jun 19;6(6):e70046. doi: 10.1002/bco2.70046. eCollection 2025 Jun.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art.上尿路尿路上皮癌的诊断与保留肾单位治疗:现状
Minerva Urol Nefrol. 2018 Jun;70(3):242-251. doi: 10.23736/S0393-2249.18.03058-8. Epub 2018 Feb 1.
6
Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma.保留肾单位手术与根治性肾输尿管切除术对上尿路尿路上皮癌患者肾功能的生存及长期影响
Eur Urol Open Sci. 2022 May 2;40:104-111. doi: 10.1016/j.euros.2022.04.007. eCollection 2022 Jun.
7
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis.上尿路尿路上皮癌内镜手术与根治性肾输尿管切除术的肿瘤学及安全性结局:一项更新的系统评价与Meta分析
Eur Urol Focus. 2023 Mar;9(2):236-240. doi: 10.1016/j.euf.2022.11.016. Epub 2022 Nov 30.
8
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
9
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Enhancing Respiration Function Evaluation and Recovery in Lung Cancer: The Interdisciplinary Approach to Postoperative Management.增强肺癌呼吸功能评估与恢复:术后管理的跨学科方法
Ann Surg Oncol. 2025 Apr;32(4):2710-2711. doi: 10.1245/s10434-024-16733-4. Epub 2024 Dec 29.
2
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma.手术效果比较:上尿路尿路上皮癌的保留肾手术
Curr Opin Urol. 2025 Jan 1;35(1):58-67. doi: 10.1097/MOU.0000000000001248. Epub 2024 Nov 7.
3
Perioperative, functional and oncologic outcomes of percutaneous ablation versus minimally invasive partial nephrectomy for clinical T1 renal tumors: outcomes from a pooled analysis.
经皮消融与微创部分肾切除术治疗 T1 期肾癌的围手术期、功能和肿瘤学结局:汇总分析结果。
J Robot Surg. 2024 Aug 6;18(1):306. doi: 10.1007/s11701-024-02052-z.
4
Trends and predictors of changes in renal function after radical nephrectomy for renal tumours.根治性肾切除术治疗肾肿瘤后肾功能变化的趋势和预测因素。
BMC Nephrol. 2024 May 21;25(1):174. doi: 10.1186/s12882-024-03601-2.
5
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2023 年更新版。
Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24.
6
Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma.保留肾单位手术与根治性肾输尿管切除术对上尿路尿路上皮癌患者肾功能的生存及长期影响
Eur Urol Open Sci. 2022 May 2;40:104-111. doi: 10.1016/j.euros.2022.04.007. eCollection 2022 Jun.
7
Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.中国中部地区上尿路尿路上皮癌患者的预后和风险因素以及膀胱癌术后复发。
BMC Urol. 2019 Apr 18;19(1):24. doi: 10.1186/s12894-019-0457-5.
8
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.保留肾单位手术与根治性肾输尿管切除术治疗上尿路上皮癌的肿瘤学结局:EAU 非肌肉浸润性膀胱癌指南小组的系统评价。
Eur Urol. 2016 Dec;70(6):1052-1068. doi: 10.1016/j.eururo.2016.07.014. Epub 2016 Jul 28.
9
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.上尿路尿路上皮癌的预后因素:对当前文献的综合回顾。
Eur Urol. 2012 Jul;62(1):100-14. doi: 10.1016/j.eururo.2012.02.030. Epub 2012 Feb 23.